Study of Lung Cancer Drug Iressa Under Way (AP)


AP - A last-chance lung cancer drug that helped patients in preliminary trials didn't do well in a follow up, a failure that surprised manufacturer AstraZeneca. The company is trying to determine why things didn't go better.

Read more...